Phreesia Inc
NYSE: PHR · HEALTHCARE · HEALTH INFORMATION SERVICES
Updated 2026-05-11
Phreesia Inc (PHR) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for PHR.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
PHR historical valuation range
Where current P/E sits in PHR's own 5Y range.
PHR intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
PHR valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 239.25x
P/S Ratio — History
Current: 1.21x
Is PHR overvalued in 2026?
Phreesia Inc (PHR) currently trades at $9.57 per share with a market capitalization of $581,503,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 43/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 239.3x.
Our discounted cash flow model estimates PHR's intrinsic value at $56.21 per share, against the current market price of $9.57. This implies a margin of safety of +77.76%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 0/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: PHR appears richly valued on our framework, with a Smart Value Score of 43/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is PHR overvalued in 2026?
Based on a Smart Value Score of 43/100, PHR appears overvalued. Current price exceeds what fundamentals currently justify.
What is PHR's fair value?
Our DCF model estimates PHR's intrinsic value at $56.21 per share, versus the current price of $9.57. This produces a margin of safety of +77.76%.
What P/E ratio does PHR trade at?
PHR trades at a P/E of 239.3x on trailing twelve-month earnings.
Is PHR a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 43/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does PHR's valuation compare to its history?
Insufficient historical valuation data exists yet for a confident percentile read on PHR.
What is PHR's Smart Value Score?
PHR's Smart Value Score is 43/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.